Skip to main content

W 434 (Pantoprazole Sodium Delayed Release 40 mg)

Pill with imprint W 434 is Yellow, Elliptical/Oval and has been identified as Pantoprazole Sodium Delayed Release 40 mg. It is supplied by Wockhardt USA.

Pantoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; gerd; gastritis/duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for W 434

Pantoprazole sodium delayed release 40 mg W 434

Pantoprazole Sodium Delayed Release

W 434
40 mg
12.00 mm
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Wockhardt USA
National Drug Code (NDC)
64679-0434 (Discontinued)
Inactive Ingredients
mannitol, silicon dioxide, sodium carbonate, calcium stearate, magnesium silicate, sodium starch glycolate type A potato, titanium dioxide, polyethylene glycol 4000, ferric oxide yellow, FD&C Blue No. 2, methacrylic acid - ethyl acrylate copolymer (1:1) type a, sodium hydroxide, triethyl citrate, polyethylene glycol 400, polyethylene glycol 6000, shellac, ferrosoferric oxide, ferric oxide red, propylene glycol, hypromelloses

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "W 434"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.